Genetic Variation of the IL-28B Promoter Affecting Gene Expression

The current standard of care for the treatment of chronic hepatitis C is pegylated interferon-α (PEG-IFNα) and ribavirin (RBV). The treatment achieves a sustained viral clearance in only approximately 50% of patients. Recent whole genome association studies revealed that single nucleotide polymorphi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugiyama, Masaya, Tanaka, Yasuhito, Wakita, Takaji, Nakanishi, Makoto, Mizokami, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201970/
https://www.ncbi.nlm.nih.gov/pubmed/22046316
http://dx.doi.org/10.1371/journal.pone.0026620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201970/
https://www.ncbi.nlm.nih.gov/pubmed/22046316
http://dx.doi.org/10.1371/journal.pone.0026620

Ejemplares similares